RxDoctor Payments Data

Michael Peters, MD

Otolaryngology/Facial Plastic Surgery · Little River, SCNPI 1194775429

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,309 of the $29,367 with a category attached, or 96.4%. AbbVie accounts for 96.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $28,377 and has fallen 98.8% since, to $333 in 2025.

$29,367in general payments, 2019–2025

Across 31 payments — averaging $947.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$28K
  • Sanofi$276
  • Aerin Medical Inc.$187
  • Integra Lifesciences Corporation$161
  • Acclarent, Inc$142
  • Medtronic$62
  • plus $210 from 10 others

What the payments were for

  • Speaking & faculty fees$28,30996%
  • Food & beverage$1,0584%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$693,428
Medicare patients
563
Services billed
2,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide38$1,446
Gentamicin Sulfate14$783
Azelastine Hcl27$653
Methylprednisolone40$409
Mupirocin40$300
Omeprazole24$255
Montelukast Sodium19$221
Azithromycin14$212
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$210
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim33$156
Cephalexin31$138
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$109

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Little River

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →